The objectives of this study were to assess the survival of CP‐CML patients treated with TKI in a daily clinical practice together with baseline and ongoing patients’ characteristics associated with a positive BCR‐ABL KD mutation detection using Sanger sequencing. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.